Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Melatonin may help treat PCOS symptoms in rats.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Most patients improved with oral contraceptives, but some needed additional treatment.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Topical antiandrogens might treat skin issues like hair growth, balding, and acne, but finding effective treatments without side effects is challenging.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.